Author

Susan B. S. King

Observed names: Susan B S King, Susan B.S. King, Susan King

Institutions: Johnson & Johnson (United States), Johnson & Johnson (Netherlands)

Observed institutions: Johnson & Johnson (United States), Helmholtz Munich, Universitätsklinikum Tübingen, Janssen (Netherlands), Johnson & Johnson (Netherlands), Institut für Immunologie, Technical University of Munich, University of Tübingen, Ludwig-Maximilians-Universität München

OpenAlex ID: A5080634735

Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity

2009 · Caspar Ohnmacht, Andrea Pullner, et al. · The Journal of Experimental Medicine · 598

DC-NK cell cross talk as a novel CD4+ T-cell–independent pathway for antitumor CTL induction

2005 · Christian Adam, Susan King, et al. · Blood · 248

Combinatorial engineering of a gene therapy vector: directed evolution of adeno‐associated virus

2005 · Luca Perabo, Jan Endell, et al. · The Journal of Gene Medicine · 141

Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency

2005 · Ulrich T. Hacker, Lisa Wingenfeld, et al. · The Journal of Gene Medicine · 63

Requirements for control of B‐cell lymphoma by NK cells

2009 · Christoph D. Brenner, Susan King, et al. · European Journal of Immunology · 35

Accumulation of Effector CD4 T Cells during Type 2 Immune Responses Is Negatively Regulated by Stat6

2008 · Susan B S King, Anna M Knorn, et al. · The Journal of Immunology · 16

Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity

2005 · Ulrich T. Hacker, Ines Schildhauer, et al. · Cancer Immunology Immunotherapy · 5

The Bacterial Swiss Army Knife: ExPEC Utilizes Multiple Resistance Mechanisms to Counteract Host Immune Responses

2025 · Eveline Weerdenburg, Susan King, et al. · Vaccines · 3

Harnessing pro-inflammatory and immunopathologic immune responses in urinary tract infections for vaccine development: it’s all about a balance

2026 · Sivakumar Periasamy, Joyce Lübbers, et al. · Frontiers in Immunology · 2

Adenovector 26 Encoded RSV Prefusion F Protein (Ad26.RSV.preF) Does Not Predispose to Enhanced Respiratory Disease in Preclinical Rodent Models

2026 · Renske Bolder, Susan B. S. King, et al. · Vaccines

Type 2 Immune Responses Is Negatively Accumulation of Effector CD4 T Cells during

2017 · David Voehringer, Susan King, et al.

Works count: 11

Citation count: 1,110

H-index: 6

I10-index: 6